SCHEMBL4902606

SCHEMBL4902606

COC(=O)c1cc(S(=O)(=O)NCCOc2ccc(C(C)(C)C)cc2)ccc1C

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
HTT P42858 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
NPSR1 Q6W5P4 2/20 0.49
LMNA P02545 2/20 0.49
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
GPR35 Q9HC97 1/20 0.44
ALPL P05186 1/20 0.44
ALPI P09923 1/20 0.44
ALPG P10696 1/20 0.44
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906098 0.91 LMNA (0.54) TDP1HTTSMN1; SMN2NPSR1LMNA
SCHEMBL4906225 0.89 NPSR1 (0.46) TDP1HTTSMN1; SMN2NPSR1LMNA
SCHEMBL4904407 0.89 SMN1; SMN2 (0.48) TDP1HTTSMN1; SMN2NPSR1LMNA
SCHEMBL4906713 0.85 TDP1 (0.59) TDP1HTTSMN1; SMN2NPSR1LMNA
SCHEMBL4899256 0.84 ALDH1A1 (0.53) HTTSMN1; SMN2LMNAALDH1A1MEN1
SCHEMBL4909535 0.83 TDP1 (0.57) TDP1HTTNPSR1LMNAALDH1A1
SCHEMBL4903029 0.82 TDP1 (0.50) TDP1HTTSMN1; SMN2NPSR1LMNA
SCHEMBL4911881 0.82 PHGDH (0.43) TDP1HTTSMN1; SMN2NPSR1LMNA
SCHEMBL4900659 0.82 ALDH1A1 (0.52) HTTSMN1; SMN2LMNAALDH1A1MEN1
SCHEMBL4906910 0.82 KMT2A (0.47) TDP1HTTSMN1; SMN2NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TDP1 3363/4885HTT 711/4885SMN1; SMN2 3271/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TDP1 3653/4885HTT 696/4885SMN1; SMN2 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.